Cortexyme gathers $76M to fund efficacy study of antibiotic for Alzheimer's

Retrieved on: 2018-05-31 05:22:30

Tags for this article:

Health

Biology

Click the tags to see associated articles and topics

Cortexyme gathers $76M to fund efficacy study of antibiotic for Alzheimer's. View article details on hiswai:

Excerpt

<div>Cortexyme's new investors in the series B round included <b>Sequoia Capital</b>, Vulcan Capital, Alphabet's Verily Life Sciences, EPIQ Capital Group, RSL ...</div>

Article found on:

View Original Article